Akebia Therapeutics Inc. (AKBA) climbed 5.33% or 0.5 to $9.88. It is about 606978 shares traded, which is 103.91% compare to the average total volume 584133. The market cap of AKBA is $477.66 million. The year to date change is -37.34%. The 52 week price range is from $8.69 to $20.25. Price of AKBA have changed -3.99% during last week. It have changed -34.59% over last month, -39.21% over last 3 months, -51.22% over last 6 months and 6.59% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 13.60. It is 37.65% above current price. The 200-day Moving Averages for AKBA is 15.30. It is 54.86% above current price. The 52-week High is 20.25. It is 104.96% from the current price. The 52-week Low is 8.69. It is -12.04% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 10.36 on 2018-03-15. Short % to float is 8.70%. There are some statistics of AKBA. It is has market cap $477.66 million. The share outstanding is 48.35 million. The average volume is 584133. The revenue is 90.67M. The percent of top 15 Institution holding is 58.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -78.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -21.77%.